BioSpace News Archive

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced that Dinesh V. Patel , Ph.D., President and Chief Executive Officer, will present at the upcoming JMP Securities Hematology and Oncology Summit taking place virtually on December 6, 2021 .

U.S. Food and Drug Administration Accepts for Priority Review supplemental Biologics License Application for Reblozyl ® (luspatercept-aamt).

AstraZeneca will underscore its ambition to redefine care with new data from across its portfolio of innovative medicines at the 2021 San Antonio Breast Cancer Symposium (SABCS) December 7-10, 2021.

Spectral Medical Inc. today announced that Chris Seto, Chief Executive Officer of Spectral Medical, is scheduled to present at the SNN Network Canada Virtual Event taking place on December 7-9, 2021.

Eurofins Environment Testing adds Omicron variant detection capabilities to its commercially available SARS-CoV-2 test portfolio.

Clarus Therapeutics Holdings, Inc. (Clarus) (Nasdaq:CRXT), today announced that it has entered into a definitive agreement to sell securities in a private placement with a leading healthcare investor.

AstraZeneca Canada, a leading innovation-driven biopharmaceutical company, has been selected for the eighth consecutive year as one of Greater Toronto’s Top Employers.

Increasing prevalence of atrial fibrillation, advancements in AFib prediction and management, and improved precision in diagnosis of this condition are some key factors expected to drive market growth.

Revive Therapeutics Ltd. is pleased to announce that the Company has decided to expand research with Bucillamine, an oral drug shown to have promising anti-viral and anti-inflammatory capabilities and is being evaluated in a current Phase 3 clinical study for COVID-19, as a potential treatment for the Omicron variant (B.1.1.529).

Growing number of healthcare cyber-attacks and threats, rise in healthcare R&D, expansion of pharmaceutical industries, increasing healthcare manufacturers, and emphasis on health care digitalization are major factors expected to drive market growth.